Biblio
Found 401 results
Author Keyword Title Type [ Year] Filters: First Letter Of Keyword is A [Clear All Filters]
“Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.”, Neurology, vol. 34, no. 7, pp. 939-44, 1984.
, “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
, “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
, “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
, “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.”, Proc Natl Acad Sci U S A, vol. 98, no. 11, pp. 6354-9, 2001.
, “Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.”, Proc Natl Acad Sci U S A, vol. 98, no. 11, pp. 6354-9, 2001.
, “Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.”, Proc Natl Acad Sci U S A, vol. 98, no. 11, pp. 6354-9, 2001.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
,